Mô tả
Graphical summary of clinical outcome measures used to evaluate cognitive function in trials of antioxidant interventions, including MMSE scores, ADAS-Cog assessments, and neuroimaging parameters.
Figure 16
ChartSource Paper
Mitochondria- and Oxidative Stress-Targeting Substances in Cognitive Decline-Related Disorders: From Molecular Mechanisms to Clinical Evidence.Cite This Figure
![Figure 16: Graphical summary of clinical outcome measures used to evaluate cognitive function in trials of antioxidant interventions, including MMSE scores, ADAS-Cog assessments, and neuroimaging parameters.]() > Source: Imane Lejri et al. "Mitochondria- and Oxidative Stress-Targeting Substances in Cognitive Decline-Rel." *Oxidative medicine and cellular longevity*, 2019. PMID: [31214285](https://pubmed.ncbi.nlm.nih.gov/31214285/)
<figure> <img src="" alt="Graphical summary of clinical outcome measures used to evaluate cognitive function in trials of antioxidant interventions, including MMSE scores, ADAS-Cog assessments, and neuroimaging parameters." /> <figcaption>Figure 16. Graphical summary of clinical outcome measures used to evaluate cognitive function in trials of antioxidant interventions, including MMSE scores, ADAS-Cog assessments, and neuroimaging parameters.<br> Source: Imane Lejri et al. "Mitochondria- and Oxidative Stress-Targeting Substances in Cognitive Decline-Rel." <em>Oxidative medicine and cellular longevity</em>, 2019. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/31214285/">31214285</a></figcaption> </figure>